SARS-COV-2 Spike S1 重组蛋白 (D614G, His & Avi)

SARS-COV-2 Spike S1 Protein (D614G, His & Avi)

产品编号 TMPK-00436

The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

规格	价格	库存
100 μg	¥ 3,250	5日内发货
500 μg	¥ 13,000	5日内发货
1 mg	¥ 21,700	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

常见问题解答

问加药后检测结果没有作用，是不是产品质量有问题？

答产品质量没有问题，都是经过两次严格质检的，HNMR确定产品结构，HPLC确定化合物纯度。同一个抑制剂由于实验材料（细胞、动物）的不同，IC50 和实验效果也是不一样的，不能照搬文献报道的方法，应该根据自己的实验设立浓度梯度，得到一个最适合的浓度。

问购买多次产品，发现颜色不同，怎么办？

答首先请您确认批次，如果是同一个批次产品，请联系技术同事核查产品颜色。如果是不同批次，请您放心，颜色不同可能是生产工艺不同而造成的，生产过程中的操作、温度、时间等因素可能会影响产品的颜色。如果您对该批次有疑虑，可在官网下载相应的质检报告，我们是对产品质量负责的。

问超声应使用什么仪器？

答建议使用“超声清洗仪”，不推荐用“超声破碎仪”。

问如何选择合适的溶剂？

答常用的溶剂包括DMSO、水、乙醇等。建议您根据抑制剂给出的溶解度参考，选择合适的溶剂。如果该抑制剂可以溶于DMSO，建议使用没有吸潮新开封的 DMSO，如果有潮气污染，很容易带来抑制剂降解或难溶的问题。如果该抑制剂可以溶于水，建议您根据实验类型选择无菌水、生理盐水、无菌 PBS 、培养基等作为溶剂。

问如何设置母液浓度？

答母液浓度需低于官网给出的溶解度，在这个范围内，根据工作液浓度设置母液浓度，细胞实验中，建议母液浓度设定在工作液浓度的 1000 倍以上。

产品信息

生物活性	Immobilized SARS-CoV-2 S1 (D614G) , His Tag at 2μg/ml (100μl/Well) on plate.Dose response curve for Human ACE2, hFc Tag with the EC50 of 23.7ng/ml determined by ELISA.
产品描述	The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
种属	SARS-CoV-2
表达系统	HEK293 Cells
标签	C-His-Avi
蛋白编号	A0A6G7K2L4
别名	Spike,S1 protein,Spike protein S1,S1 protein,S glycoprotein Subunit1
蛋白构建	Gln14-Arg683(D614G)
蛋白纯度	> 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC
分子量	77.9 kDa (predicted). Due to glycosylation, the protein migrates to 110-120 kDa based on Tris-Bis PAGE result.
内毒素	< 1 EU/μg by the LAL method.
缓冲液	Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS (pH 7.4). Typically, 8% trehalose is incorporated as a protective agent before lyophilization.
复溶方法	Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
存储	It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice.
研究背景	The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

SARS-COV-2 Spike S1 Protein (D614G, His & Avi)

SARS-COV-2 Spike S1 Protein (D614G, His & Avi)

产品信息

参考文献

SCI 文献

计算器

技术支持